Bayer AG logo

BAYN - Bayer AG Share Price

€65.95 0.2  0.2%

Last Trade - 7:00am

Sector
Healthcare
Size
Large Cap
Market Cap £53.53bn
Enterprise Value £87.90bn
Revenue £39.78bn
Position in Universe 17th / 1025
Bullish
Bearish
Unlock BAYN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BAYN Revenue Unlock BAYN Revenue

Net Income

BAYN Net Income Unlock BAYN Revenue

Normalised EPS

BAYN Normalised EPS Unlock BAYN Revenue

PE Ratio Range

BAYN PE Ratio Range Unlock BAYN Revenue

Dividend Yield Range

BAYN Dividend Yield Range Unlock BAYN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BAYN EPS Forecasts Unlock BAYN Revenue
Profile Summary

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since November 28, 1997
No. of Shareholders: n/a
No. of Employees: 115,498
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Global 100,
Exchange Frankfurt Stock Exchange (Dual Listing)
Shares in Issue 932,556,122
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BAYN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.